James M Swanson Selected Research

Methylphenidate (Ritalin)

10/2018	Risk of Bias and Quality of Evidence for Treatment of ADHD With Stimulant Medication.
1/2018	Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.
1/2017	Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder.
1/2013	Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
11/2012	Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
6/2012	Chronic exposure to methylphenidate impairs appendicular bone quality in young rats.
1/2012	Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
1/2010	Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task.
5/2009	Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
11/2008	Transdermal methylphenidate more effective than placebo for treating ADHD.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James M Swanson Research Topics

Disease

95	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2022 - 01/2002
12	Substance-Related Disorders (Drug Abuse) 03/2020 - 08/2007
3	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2006 - 12/2005
2	Headache (Headaches) 05/2006 - 12/2005
1	Growth Disorders 01/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Conduct Disorder (Conduct Disorders) 03/2020
1	Marijuana Use 03/2020
1	Oppositional Defiant Disorder 03/2020
1	Binge Drinking 04/2016
1	Autistic Disorder (Autism) 01/2016
1	Arthrogryposis 01/2013
1	Contracture 01/2013
1	Opsismodysplasia 01/2013
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2012
1	Mental Disorders (Mental Disorder) 10/2009
1	Sleep Deprivation 05/2009
1	Tic Disorders (Tic Disorder) 06/2006
1	Weight Loss (Weight Reduction) 05/2006
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2006
1	Dyskinesias (Dyskinesia) 02/2000
1	Tardive Dyskinesia 02/2000

Drug/Important Bio-Agent (IBA)

36	Pemetrexed (MTA)FDA Link 02/2022 - 05/2002
27	Methylphenidate (Ritalin)FDA LinkGeneric 10/2018 - 03/2002
15	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 02/2000
9	Pharmaceutical PreparationsIBA 03/2020 - 03/2002
6	Modafinil (Provigil)FDA Link 05/2006 - 01/2003
4	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018 - 02/2007
4	TabletsIBA 05/2006 - 12/2005
3	Illicit Drugs (Recreational Drugs)IBA 03/2020 - 01/2018
3	Cocaine (Cocaine HCl)IBA 01/2018 - 02/2007
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 01/2002
3	AdderallIBA 10/2003 - 06/2003
2	CatecholaminesIBA 01/2021 - 05/2003
2	Biological ProductsIBA 11/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 10/2007
2	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 11/2013 - 06/2006
2	RacloprideIBA 05/2009 - 08/2007
2	SLI381IBA 06/2003 - 06/2003
2	Amphetamine (Amfetamine)FDA LinkGeneric 06/2003 - 06/2003
1	TEMPOIBA 01/2022
1	Nicotine FDA Link 04/2016
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016
1	trans-sodium crocetinate (crocetin)IBA 12/2015
1	Contractile ProteinsIBA 01/2013
1	Inositol (Myoinositol)IBA 01/2013
1	Phosphates (Orthophosphate)IBA 01/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013
1	PolyphosphatesIBA 01/2013
1	Central Nervous System StimulantsIBA 01/2010
1	Complement System Proteins (Complement)IBA 10/2009
1	LigandsIBA 09/2009
1	CarbonIBA 08/2007
1	Pemoline (Cylert)FDA Link 06/2006
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 05/2006
1	Dexmethylphenidate Hydrochloride FDA LinkGeneric 11/2004
1	Therapeutic UsesIBA 11/2003
1	SaltsIBA 06/2003
1	Delayed-Action PreparationsIBA 06/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2003
1	Epinephrine (Adrenaline)FDA LinkGeneric 05/2003
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2003
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2003
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2000
1	Antipsychotic Agents (Antipsychotics)IBA 02/2000
1	Haloperidol (Haldol)FDA LinkGeneric 02/2000

Therapy/Procedure

47	Combined Modality Therapy 02/2022 - 05/2002
2	Drug Therapy (Chemotherapy) 06/2006 - 01/2003
1	Treatment Delay 01/2021
1	Aftercare (After-Treatment) 05/2009
1	Therapeutics 01/2003